diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/DM2013417-22diaendo-3846Research ArticleГенетикаGeneticsАссоциация полиморфных маркеров rs7903146 гена TCF7L2 и rs1801282 гена PPARG (Pro12Ala) с сахарным диабетом 2 типа в Новосибирской областиRs7903146 variant of TCF7L2 gene and rs18012824 variant of PPARG2 gene (Pro12Ala) are associated with type 2 diabetes mellitus in Novosibirsk populationБондарьИрина АркадьевнаBondar'Irina Arkad'evna

MD, PhD, Professor, Head of Endocrinology Department

bondaria@oblmed.nsk.ruФилипенкоМаксим ЛеонидовичFilipenkoMaksim Leonidovich

PhD, Head of Farmacogenomics Laboratory

max@niboch.nsc.ruШабельниковаОлеся ЮрьевнаShabel'nikovaOlesya Yur'evna

кандидат медицинских наук, руководитель областного диабетологического центра

MD, PhD, Head of Regional Diabetic Center

odc@oblmed.nsk.ruСоколоваЕкатерина АлександровнаSokolovaEkaterina Alexandrovna

инженер лабораторнии фармакогеномики

Researcher in Farmacogenomics Laboratory

max@niboch.nsc.ruГБОУ ВПО Новосибирский Государственный медицинский университет, НовосибирскРоссияNovosibirsk State Medical University, NovosibirskRussian FederationФГБУН Институт химической биологии и фундаментальной медицины, НовосибирскРоссияInstitute of Chemical Biology and Fundamental Medicine, NovosibirskRussian FederationГБУЗ НСО Новосибирская областная клиническая больница, НовосибирскРоссияNovosibirsk State Regional Hospital, NovosibirskRussian Federation2013181220131641722Copyright © Бондарь И.А., Филипенко М.Л., Шабельникова О.Ю., Соколова Е.А., 20132013Бондарь И.А., Филипенко М.Л., Шабельникова О.Ю., Соколова Е.А.Bondar' I.A., Filipenko M.L., Shabel'nikova O.Y., Sokolova E.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/3846сахарный диабет 2 типагенетикадисфункция бета-клеток: инсулинорезистентностьPPARGTCF7L2type 2 diabetes mellitusgeneticsbeta-cell dysfunctioninsulin resistancePPARG2TCF7L2Российский Фонд Фундаментальных Исследований (РФФИ), грант № 13-04-00520ReferencesRobertson RP. The battered β-cell: usual suspects and guilt by association. J Clin Endocrinol Metab. 2011;96(12):3672–3674. doi: 10.1210/jc.2011–2960Robertson RP. The battered β-cell: usual suspects and guilt by association. J Clin Endocrinol Metab. 2011;96(12):3672–3674. doi: 10.1210/jc.2011–2960Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, et al. A Pro12Ala substitution in PPARg2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998;20:84–287.Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, et al. A Pro12Ala substitution in PPARg2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998;20:84–287.Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, et al. Molecular scanning of the human Peroxisome proliferator activated receptor g (hPPARg) gene in diabetic Caucasians: identification of a Pro12Ala PPARg2 missense mutation. Biochem Biophys Res Commun. 1997;241(2):270–274. doi: 10.1006/bbrc.1997.7798Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, et al. Molecular scanning of the human Peroxisome proliferator activated receptor g (hPPARg) gene in diabetic Caucasians: identification of a Pro12Ala PPARg2 missense mutation. Biochem Biophys Res Commun. 1997;241(2):270–274. doi: 10.1006/bbrc.1997.7798Kaydashev IP, Rasin AM, Shlykova OA, Gorbas IM, Smirnova IP, Petrushov AV, et al. Frequency of Pro12Ala-polymorphism of the gene PPARγ2 in the Ukrainian population and its possible relation to the development of the metabolic syndrome. Cytology and Genetics. 2007;41(5):298–302. doi: 10.3103/S0095452707050076Kaydashev IP, Rasin AM, Shlykova OA, Gorbas IM, Smirnova IP, Petrushov AV, et al. Frequency of Pro12Ala-polymorphism of the gene PPARγ2 in the Ukrainian population and its possible relation to the development of the metabolic syndrome. Cytology and Genetics. 2007;41(5):298–302. doi: 10.3103/S0095452707050076Потапов ВА. Поиск генетических маркеров, определяющих предрасположенность к сахарному диабету 2 типа. Автореферат … канд. биол. наук. M; 2010. 24c. [Potapov VA. Poisk geneticheskikh markerov, opredelyayushchikh predraspolozhennost' k sakharnomu diabetu 2 tipa [dissertation]. Moscow; 2010. 24p]Потапов ВА. Поиск генетических маркеров, определяющих предрасположенность к сахарному диабету 2 типа. Автореферат … канд. биол. наук. M; 2010. 24c. [Potapov VA. Poisk geneticheskikh markerov, opredelyayushchikh predraspolozhennost' k sakharnomu diabetu 2 tipa [dissertation]. Moscow; 2010. 24p]Reynisdottir I, Thorleifsson G, Benediktsson R, Sigurdsson G, Emilsson V, Einarsdottir AS, et al. Localization of a Susceptibility Gene for Type 2 Diabetes to Chromosome 5q34–q35.2. The American Journal of Human Genetics. 2003;73(2):323–335. doi: 10.1086/377139Reynisdottir I, Thorleifsson G, Benediktsson R, Sigurdsson G, Emilsson V, Einarsdottir AS, et al. Localization of a Susceptibility Gene for Type 2 Diabetes to Chromosome 5q34–q35.2. The American Journal of Human Genetics. 2003;73(2):323–335. doi: 10.1086/377139Grant SFA, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.. Nat Genet. 2006;38(3):320–323. doi: 10.1038/ng1732Grant SFA, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.. Nat Genet. 2006;38(3):320–323. doi: 10.1038/ng1732Florez JC. The new type 2 diabetes gene TCF7L2. Curr Opin Clin Nutr Metab Care. 2007;10(4):391–396. doi: 10.1097/MCO.0b013e3281e2c9beFlorez JC. The new type 2 diabetes gene TCF7L2. Curr Opin Clin Nutr Metab Care. 2007;10(4):391–396. doi: 10.1097/MCO.0b013e3281e2c9beCauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med. 2007;85(7):777–782. doi: 10.1007/s00109-007-0203-4Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med. 2007;85(7):777–782. doi: 10.1007/s00109-007-0203-4Cecil JE, Watt P, Palmer CN, Hetherington M. Energy balance and food intake: the role of PPARgamma gene polymorphisms. Physiol Behav. 2006;88(3):227–233. doi: 10.1016/j.physbeh.2006.05.028Cecil JE, Watt P, Palmer CN, Hetherington M. Energy balance and food intake: the role of PPARgamma gene polymorphisms. Physiol Behav. 2006;88(3):227–233. doi: 10.1016/j.physbeh.2006.05.028Lyssenko V, Lupi R, Marchetti P, del Guerra S,, Orho-Melander M, Almgren P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest. 2007;117:2155–2163.Lyssenko V, Lupi R, Marchetti P, del Guerra S,, Orho-Melander M, Almgren P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest. 2007;117:2155–2163.Schafer SA, Machicao F, Fritsche A, Haring HU, Kantartzis K. New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms. Diabetes Res Clin Pract. 2011;93(Suppl 1):9–24. doi: 10.1016/S0168-8227(11)70008-0Schafer SA, Machicao F, Fritsche A, Haring HU, Kantartzis K. New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms. Diabetes Res Clin Pract. 2011;93(Suppl 1):9–24. doi: 10.1016/S0168-8227(11)70008-0Farch K, Pilgaard K, Knop FK, Hansen T, Pedersen O, Jorgensen T, et al. Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele. Diabetes Obes Metab. 2013;15(1):91–95. doi: 10.1111/j.1463-1326.2012.01675.xFarch K, Pilgaard K, Knop FK, Hansen T, Pedersen O, Jorgensen T, et al. Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele. Diabetes Obes Metab. 2013;15(1):91–95. doi: 10.1111/j.1463-1326.2012.01675.xLe Bacquer O, Kerr-Conte J, Gargani S, Delalleau N, Huyvaert M, Gmyr V, et al. TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals. Diabetologia 2012;55(10):2677–2681. doi: 10.1007/s00125-012-2660-8Le Bacquer O, Kerr-Conte J, Gargani S, Delalleau N, Huyvaert M, Gmyr V, et al. TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals. Diabetologia 2012;55(10):2677–2681. doi: 10.1007/s00125-012-2660-8Lukacs K, Hosszufalusi N, Dinya E, Bakacs M, Madacsy L, Panczel P. The type 2 diabetes-associated variant inTCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the gene effect is modified by obesity: a meta-analysis and an individual study. Diabetologia. 2012;55(3):689–693. doi: 10.1007/s00125-011-2378-zLukacs K, Hosszufalusi N, Dinya E, Bakacs M, Madacsy L, Panczel P. The type 2 diabetes-associated variant inTCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the gene effect is modified by obesity: a meta-analysis and an individual study. Diabetologia. 2012;55(3):689–693. doi: 10.1007/s00125-011-2378-z

The authors declare that there are no conflicts of interest present.